STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CRTX CORTEXYME INCORPORATED StockScouter® Report

4

StockScouter® Score

CORTEXYME INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral
  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like CRTX

 

Concerns

  • The 50-day moving average for CRTX is below its 200-day moving average. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

C
C
N/A
C

Previous Ratings

2
1